https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-03-01 / Br. J. Haematol. 2000 Mar;108(4):805-16
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-03-01 / Br. J. Haematol. 2000 Mar;108(4):805-162000-03-01 00:00:002019-02-15 08:51:14Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-02-01 / Curr. Opin. Mol. Ther. 2000 Feb;2(1):20-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-02-01 / Curr. Opin. Mol. Ther. 2000 Feb;2(1):20-82000-02-01 00:00:002019-02-15 08:45:17Clinical applications of dendritic cell vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-02-01 / J. Clin. Virol. 2000 Feb;16(1):1-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-02-01 / J. Clin. Virol. 2000 Feb;16(1):1-152000-02-01 00:00:002019-02-15 09:22:30Newcastle disease virus (NDV): brief history of its oncolytic strains
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-02-01 / Med. Oncol. 2000 Feb;17(1):2-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-02-01 / Med. Oncol. 2000 Feb;17(1):2-152000-02-01 00:00:002019-02-15 08:51:15Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-02-01 / Biol Trace Elem Res 2000 Feb;73(2):97-111
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-02-01 / Biol Trace Elem Res 2000 Feb;73(2):97-1112000-02-01 00:00:002000-02-01 00:00:00Selenium and immunocompetence in patients with head and neck cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-01-01 / Int. J. Radiat. Oncol. Biol. Phys. 2000 Jan;46(1):179-85
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-01-01 / Int. J. Radiat. Oncol. Biol. Phys. 2000 Jan;46(1):179-852000-01-01 00:00:002000-01-01 00:00:00Temperature-dependent changes in physiologic parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-12-01 / Br. J. Haematol. 1999 Dec;107(3):648-55
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-12-01 / Br. J. Haematol. 1999 Dec;107(3):648-551999-12-01 00:00:002019-02-15 08:51:16Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-11-01 / Int J Hyperthermia 1999 Nov-Dec;15(6):475-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-11-01 / Int J Hyperthermia 1999 Nov-Dec;15(6):475-861999-11-01 00:00:001999-11-01 00:00:00Tumour cell kinetics as predictors of response in canine lymphoma treated with chemotherapy alone or combined with whole body hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-07-02 / Int. J. Cancer 1999 Jul;82(1):121-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-07-02 / Int. J. Cancer 1999 Jul;82(1):121-41999-07-02 00:00:002019-02-15 08:39:05Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-07-01 / Anticancer Res. 1999 Jul-Aug;19(4C):3403-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-07-01 / Anticancer Res. 1999 Jul-Aug;19(4C):3403-81999-07-01 00:00:002019-02-15 08:39:25Deep hyperthermia with radiofrequencies in patients with liver metastases from colorectal cancer
